title: Treatment of idiopathic intracranial hypertension: Is there a place for octreotide?
authors.forename: Spyros N
authors.initials: SN
authors.lastname: Deftereos
authors.forename: Gregory
authors.initials: G
authors.lastname: Panagopoulos
authors.forename: Dimitra
authors.initials: D
authors.lastname: Georgonikou
authors.forename: Clementine E
authors.initials: CE
authors.lastname: Karageorgiou
authors.forename: Elissaios
authors.initials: E
authors.lastname: Karageorgiou
authors.forename: George
authors.initials: G
authors.lastname: Piadites
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use*; D011559:Pseudotumor Cerebri / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide